TRPV4-mediated channelopathies

Channels

Volumn 4, Issue 4, 2010, Pages

  Verma, Pratibha ^a   Kumar, Ashutosh ^a   Goswami, Chandan ^a  

^a NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Mutation; Surface expression; TRPV4; Ubiquitin; Vesicle

Indexed keywords

CATION CHANNEL; VANILLOID RECEPTOR 4;

ANIMAL CELL; CHANNELOPATHY; GENE MUTATION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OLIGOMERIZATION; REVIEW; SPINAL MUSCULAR ATROPHY; UBIQUITINATION;

EID: 77956487722     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.4.4.12905     Document Type: Review

References (80)

1. Plant TD, Strotmann R. TRPV4. Handb Exp Pharmacol 2007; 179:189-205.
2. Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci USA 2003; 100:14531-6.
3. Nilius B, Owsianik G. Transient receptor potential chanellopathies. Pflugers Arch 2010; 460:437-50.
4. Auer-Grumbach M, Olschewski A, Papic L, Kremer H, McEntagart ME, Uhrig S, et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 2010; 42:160-4.
5. Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 2010; 42:170-4.
6. Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010; 42:165-9.
7. Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, et al. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet 2008; 40:999-1003.
8. Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: From structure to disease. Prog Biophys Mol Biol 2009; (Epub ahead of print).
9. Shigematsu H, Sokabe T, Danev R, Tominaga M, Nagayama K. A 3.5 nm structure of rat TRPV4 cation channel revealed by zernike phase-contrast cryo-EM. J Biol Chem 2010; 285:11210-8.
10. Moiseenkova-Bell VY, Stanciu LA, Serysheva II, Tobe BJ, Wensel TG. Structure of TRPV1 channel revealed by electron cryomicroscopy. Proc Natl Acad Sci USA 2008; 105:7451-5.
11. Gaudet R. TRP channels entering the structural era. J Physiol 2008; 586:3565-75.
12. Denker SP, Barber DL. Ion transport proteins anchor and regulate the cytoskeleton. Curr Opin Cell Biol 2002; 14:214-20.
13. Lepage PK, Boulay G. Molecular determinant of assembly. J Biochem Soc Trans 2007; 35:81-3.
14. Garcia-Elias A, Lorenzo IM, Vicente R, Valverde MA. IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli via a calmodulin-binding site. J Biol Chem 2008; 283:31284-8.
15. 2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal Calmodulin binding site. J Biol Chem 2003; 278:26541-9.
16. 2+-dependent potentiation in the cation channel TRPV4. PLoSOne 2010; 5:10580.
17. Goswami C, Hucho T, Hucho F. Identification and characterisation of novel tubulin-binding motifs located within the C-terminus of TRPV1. J Neurochem 2007; 101:250-62.
18. Suzuki M, Hirao A, Mizuno A. Microfilament-associated Protein 7 increases the membrane expression of Transient Receptor Potential Vanilloid 4. J Biol Chem 2003; 278:51448-53.
19. Goswami C, Khun J, Heppenstall P, Hucho T. Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulations in cultured cells. Plos One (Accepted) 2010.
20. Ramadass R, Becker D, Jendrach M, Bereiter-Hahn J. Spectrally and spatially resolved fluorescence lifetime imaging in living cells: TRPV4-microfilament interactions. Arch Biochem Biophys 2007; 463:27-36.
21. Bird TD. Charcot-Marie-Tooth Neuropathy Type 2. GeneReviews 2010.
22. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105:587-97.
23. Tian W, Fu Y, Garcia-Elias A, Fernández-Fernández JM, Vicente R, Kramer PL, et al. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci 2009; 106:14034-9.
24. Camacho N, Krakow D, Johnykutty S, Katzman PJ, Pepkowitz S, Vriens J, et al. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia. Am J Med Genet A 2010; 152:1169-77.
25. Nishimura G, Dai J, Lausch E, Unger S, Megarbané A, Kitoh H, et al. Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2) and parastremmatic dysplasia are caused by TRPV4 mutations. Am J Med Genet A 2010; 152:1443-9.
26. Dai J, Cho TJ, Unger S, Lausch E, Nishimura G, Kim OH, et al. TRPV4-pathy, a novel channelopathy affecting diverse systems. J Hum Genet 2010; (Epub ahead of print).
27. Krakow D, Vriens J, Camacho N, Luong P, Deixler H, Funari TL, et al. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet 2009; 84:307-15.
28. Tabuchi K, Suzuki M, Mizuno A, Hara A. Hearing impairment in TRPV4 knockout mice. Neurosci Lett 2005; 382:304-8.
29. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 2007; 117:3453-62.
30. Mizuno A, Matsumoto N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiology 2003; 285:96-101.
31. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. Biol Chem 2003; 278:22664-8.
32. D'hoedt D, Owsianik G, Prenen J, Cuajungco MP, Grimm C, Heller S, et al. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem 2008; 283:6272-80.
33. 2+. Cell Calcium 2003; 33:489-95.
34. Phelps CB, Wang RR, Choo SS, Gaudet R. Differential regulation of TRPV1, TRPV3 and TRPV4 sensitivity through a conserved binding site on ankyrin repeat domain. J Biol Chem 2009; 285:731-40.
35. Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, Nilius B. Cell swelling, heat and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci USA 2004; 101:396-401.
36. Hu H, Grandl J, Bandell M, Petrus M, Patapoutian A. Two amino acid residues determine 2-APB sensitivity of the ion channels TRPV3 and TRPV4. Proc Natl Acad Sci USA 2009; 106:1626-31.
37. Vriens J, Owsianik G, Janssens A, Voets T, Nilius B. Determinants of 4-Phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4. J Biol Chem 2007; 282:12796-803.
38. Loukin S, Su Z, Zhou X, Kung C. Forward genetic analysis reveals multiple gating mechanisms of TRPV4. J Biol Chem 2010; 285:19884-90.
39. Xu H, Fu Y, Tian W, Cohen DM. Glycosylation of the osmoresponsive transient receptor potential channel TRPV4 on Asn-651 influences membrane trafficking. Am J Physiol Renal Physiol 2006; 290:1103-9.
40. Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, et al. Molecular Determinants of Permeation through the Cation Channel TRPV4. J Biol Chem 2002; 277:33704-10.
41. Peng H, Lewandrowski U, Müller B, Sickmann A, Walz G, Wegierski T. Identification of a Protein Kinase C-dependent phosphorylation site involved in sensitization of TPV4 channel. Biochem Biophys Res Commun 2010; 391:1721-5.
42. Wang Y, Fu X, Gaiser S, Köttgen M, Kramer-Zucker A, Walz Gand, et al. OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum. J Biol Chem 2007; 282:36561-70.
43. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002; 277:47044-51.
44. Wegierski T, Hill K, Schaefer M, Walz G. The HECT ubiquitin ligase AIP4 regulates the cell surface expression of select TRP channels. EMBO J 2006; 25:5659-69.
45. Yu Y, Ulbrich MH, Li MH, Buraei Z, Chen XZ, Ong AC, et al. Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc Natl Acad Sci 2009; 106:11558-63.
46. Goswami C, Islam MS. TRP channels: What's happening? Reflections in the wake of the 2009 TRP Meeting, Karolinska Institutet, Stockholm. Channels 2010; 4:1-12.
47. 2+ channels TRPV5 and TRPV6. EMBO J 2003; 22:776-85.
48. Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, et al. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem 2006; 281:13588-95.
49. Rutter AR, Ma QP, Leveridge M, Bonnert TP. Heteromerization and colocalization of TrpV1 and TrpV2 in mammalian cell lines and rat dorsal root ganglia. Neuroreport 2005; 16:1735-9.
50. Cheng W, Yang F, Takanishi LC, Zheng J. Thermosensitive TRPV channel subunits co-assemble into heteromeric channels with intermediate conductance and gating. J Gen Physiol 2007; 129:191-207.
51. Lepage PK, Lussier MP, Barajas-Martinez H, Bousquet SM, Blanchard AP, Francoeur N, et al. Identification of two domains involved in the assembly of Transient Receptor Potential Canonical channels. J Biol Chem 2006; 281:30356-64.
52. Schaefer M. Homo- and heteromeric assembly of TRP channel subunits. Pflugers Arch 2005; 451:35-42. (Pubitemid 41424905)
53. Hellwig N, Albrecht N, Harteneck C, Schultz G, Schaefer M. Homo and hetero assembly of TRPV channel subunits. J Cell Sci 2005; 118:917-28.
54. Schindl R, Romanin C. Assembly domains in TRP channels. Biochem Soc Trans 2007; 35:84-5.
55. Garcia-Sanz N, Fernandez-Carvajal A, Morenilla-Palao C, Planells-Cases R, Fajardo-Sanchez E, Fernandez-Ballester G, et al. Identification of a tetramerization domain in the C-terminus of the Vanilloid Receptor. J Neurosci 2004; 24:5307-14.
56. 2+-selective Transient Receptor Potential V channel architecture and function require a specific Ankyrin Repeat. J Biol Chem 2004; 279:34456-63.
57. Arniges M, Fernandez-Fernandez JM, Albrecht N, Schaefer M, Valverde MA. Human TRPV4 channel splice variants revealed a key role of Ankyrin domains in multimerization and trafficking. J Biol Chem 2005; 281:1580-6.
58. Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, et al. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 2003; 39:497-511.
59. Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003; 4:181-91.
60. Alcock F, Swanton E. Mammalian OS-9 is upregulated in response to E.R stress and facilitates ubiquitination of misfolded glycoprotein. J Mol Biol 2009; 385:1032-42.
61. Becker D, Müller M, Leuner K, Jendrach M. The C-terminal domain of TRPV4 is essential for plasma membrane localization. Mol Membr Biol 2008; 25:139-51.
62. Miranda M, Sorkin A. Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms. Mol Interv 2007; 7:157-67.
63. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 2004; 279:25665-72.
64. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82:373-428.
65. Pizzirusso M, Chang A. Ubiquitin-mediated targeting of mutant plasma membrane ATPase, Pma1-7 to the endosomal vacuolar system in yeast. Mol Biol Cell 2004; 15:2401-9.
66. Pickaart CM. Targetting substrate to the 26S Proteasome. FASEB J 1997; 11:1055-66.
67. Raiborg C, Rusten TE, Stenmark H. Protein sorting into multi-vesicular endosomes. Curr Opin Cell Biol 2003; 15:446-55.
68. Katzmann DJ, Babst M, Emr DS. Ubiquitin dependent sorting into multivesicular body pathway requires the function of conserved endosomal protein sorting complex ESCRT-1. Cell 2001; 106:145-55.
69. Katzmann DJ, Sarkar S, Chu T, Audhya A, Emr SD. Multivesicular body sorting: Ubiquitin ligase Rsp5 is required for the modification and sorting of carboxypeptidase S. Mol Biol Cell 2004; 15:13943-53.
70. Woodman P. ESCRT proteins, endosome organization and mitogenic receptor downregulation. Biochem Soc Trans 2009; 37:146-50.
71. d'Azzo A, Bongiovanni A, Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 2005; 6:429-41.
72. Shikano S, Li M. Membrane receptor trafficking: evidence of proximal and distal zones conferred by two independent endoplasmic reticulum localization signals. Proc Natl Acad Sci 2003; 100:5783-8.
73. Garcia-Sanz N, Valente P, Gomis A, Fernandez-Carvajal A, Fernandez-Ballester G, Viana F, et al. A role of the transient receptor potential domain of vanilloid receptor I in channel gating. J Neurosci 2007; 27:11641-50.
74. Goel M, Sinkins WG, Schilling WP. Selective association of TRPC channel subunits in rat brain synaptosomes. J Biol Chem 2002; 277:48303-10.
75. 2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol 2006; 26:303-12.
76. 2+ channel transient receptor potential cation channel V5 (TRPV5). J Biol Chem 2004; 279:26351-7.
77. Goswami C, Rademacher N, Smalla KH, Kalscheuer V, Ropers HH, Gundelfinger ED, et al. TRPV1 acts as a synaptic protein and regulates vesicle recycling. J Cell Sci 2010; 123:2045-57.
78. Hu J, Wittekind GS, Barr MM. STAM and Hrs down-regulate ciliary TRP receptors. Mol Biol Cell 2007; 18:3277-89.
79. Stokes AJ, Wakano C, Del Carmen KA, Koblan-Huberson M, Turner H. Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2. J Cell Biochem 2005; 94:669-83.
80. Phelps CB, Huang RJ, Lishko PV, Wang RR, Gaudet R. Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels. Biochemistry 2008; 47:2476-84.